Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $128.66 billion. The enterprise value is $138.10 billion.
| Market Cap | 128.66B |
| Enterprise Value | 138.10B |
Important Dates
The last earnings date was Wednesday, October 23, 2024, before market open.
| Earnings Date | Oct 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.47 billion shares outstanding. The number of shares has increased by 1.89% in one year.
| Current Share Class | 1.47B |
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +1.89% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 91.91% |
| Float | 1.47B |
Valuation Ratios
The trailing PE ratio is 72.14 and the forward PE ratio is 32.39. BSX's PEG ratio is 2.38.
| PE Ratio | 72.14 |
| Forward PE | 32.39 |
| PS Ratio | 8.09 |
| Forward PS | 7.34 |
| PB Ratio | 6.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 59.88 |
| P/OCF Ratio | 43.97 |
| PEG Ratio | 2.38 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.99, with an EV/FCF ratio of 64.05.
| EV / Earnings | 77.02 |
| EV / Sales | 8.68 |
| EV / EBITDA | 33.99 |
| EV / EBIT | 48.81 |
| EV / FCF | 64.05 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.48 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 2.70 |
| Debt / FCF | 5.22 |
| Interest Coverage | 9.76 |
Financial Efficiency
Return on equity (ROE) is 8.92% and return on invested capital (ROIC) is 5.83%.
| Return on Equity (ROE) | 8.92% |
| Return on Assets (ROA) | 4.90% |
| Return on Capital (ROIC) | 5.83% |
| Revenue Per Employee | $331,479 |
| Profits Per Employee | $37,354 |
| Employee Count | 48,000 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.93 |
Taxes
In the past 12 months, BSX has paid $414.00 million in taxes.
| Income Tax | 414.00M |
| Effective Tax Rate | 18.81% |
Stock Price Statistics
The stock price has increased by +61.44% in the last 52 weeks. The beta is 0.80, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +61.44% |
| 50-Day Moving Average | 85.26 |
| 200-Day Moving Average | 75.91 |
| Relative Strength Index (RSI) | 56.24 |
| Average Volume (20 Days) | 6,868,057 |
Short Selling Information
The latest short interest is 12.91 million, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 12.91M |
| Short Previous Month | 10.92M |
| Short % of Shares Out | 0.88% |
| Short % of Float | 0.88% |
| Short Ratio (days to cover) | 1.91 |
Income Statement
In the last 12 months, BSX had revenue of $15.91 billion and earned $1.79 billion in profits. Earnings per share was $1.21.
| Revenue | 15.91B |
| Gross Profit | 10.94B |
| Operating Income | 2.83B |
| Pretax Income | 2.15B |
| Net Income | 1.79B |
| EBITDA | 4.06B |
| EBIT | 2.83B |
| Earnings Per Share (EPS) | $1.21 |
Balance Sheet
The company has $2.50 billion in cash and $11.26 billion in debt, giving a net cash position of -$8.76 billion or -$5.94 per share.
| Cash & Cash Equivalents | 2.50B |
| Total Debt | 11.26B |
| Net Cash | -8.76B |
| Net Cash Per Share | -$5.94 |
| Equity (Book Value) | 20.96B |
| Book Value Per Share | 14.05 |
| Working Capital | 2.85B |
Cash Flow
In the last 12 months, operating cash flow was $2.94 billion and capital expenditures -$780.00 million, giving a free cash flow of $2.16 billion.
| Operating Cash Flow | 2.94B |
| Capital Expenditures | -780.00M |
| Free Cash Flow | 2.16B |
| FCF Per Share | $1.46 |
Margins
Gross margin is 68.74%, with operating and profit margins of 17.78% and 11.26%.
| Gross Margin | 68.74% |
| Operating Margin | 17.78% |
| Pretax Margin | 13.83% |
| Profit Margin | 11.26% |
| EBITDA Margin | 25.54% |
| EBIT Margin | 17.78% |
| FCF Margin | 12.27% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.89% |
| Shareholder Yield | -1.89% |
| Earnings Yield | 1.39% |
| FCF Yield | 1.67% |
Analyst Forecast
The average price target for BSX is $93.73, which is 7.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $93.73 |
| Price Target Difference | 7.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (5Y) | 9.87% |
| EPS Growth Forecast (5Y) | 28.56% |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 4.3 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.3 |
| Piotroski F-Score | 6 |